What Chemo Leaves Behind
After chemotherapy ends, some cancer cells stop dividing but refuse to die. Their inflammatory signals fuel recurrence. Scientists have found their weakness.
What are Xenobots?
Xenobots are described as living robots made from frog cells. That framing is reasonable. It is also wrong in ways that matter — and the accurate version is stranger and more important.
The Income Floor
hat happens when machines do all the work? The science and history of Universal Basic Income — from 1795 England to the world’s largest experiment in Kenya.
The Hollow Mind
Without hormones, pain, gender, or the subconscious — what would a superintelligent mind actually be? The neuroscience of what makes us us, and what silicon cannot replace.
The Recursive Moment
Recursive self-improvement is live. Three AI systems now rewrite their own code. The last frontier before AGI is embodiment. And the clock is running.
The Flood: China’s Four-Model Blitz
Between April 7-24, 2026, four Chinese labs released frontier-class open-weights AI models at prices as low as $0.28/M tokens — roughly 1% of Western equivalents. Here’s what that means.
The Model They Won’t Release (Mythos)
Anthropic’s Mythos scores 93.9% on SWE-Bench and can find zero-day exploits autonomously. It’s the most capable AI ever built — and no one outside Project Glasswing can touch it.
The Foundry Wars
Samsung’s Texas fab went from ‘no customers’ to Tesla’s $16.5B chip partner. Inside the race that will decide who controls AI’s foundational hardware.
Beyond AlphaFold
AlphaFold decoded protein shapes. Now a new generation of AI doesn’t just read biology – it writes it, designing custom protein binders that can target almost any disease.
The Files Are Open
The Pentagon released 161 classified UAP files on 8 May 2026. They show craft doing things that shouldn’t be possible. They do not confirm extraterrestrial origin. Both things are true.
Buy me a coffee